This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
Filters
[Clear]
- Price Sensitive: Yes
JHL | Appendix 4E and 2017 Annual Report | PRICE SENSITIVE | 27/02/18 | |
JHL Appendix 4E and 2017 Annual Report | |||
27/02/18 | PRICE SENSITIVE | ||